Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Sarcopenia as a Risk of Modern Obesity Treatments: A Review of Molecular Mechanisms and Prevention Strategies

The Indonesian Biomedical Journal · Vol. 17 No. 6 (2025) · hlm. 511–526

DOI
10.18585/inabj.v17i6.3583
ISSN
2085-3297, 2355-9179
Terbit
2025-12-27
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

While lifestyle interventions and metabolic surgery for obesity have limitations, incretin-based therapies have emerged as highly effective treatments. However, their success is shadowed by a significant risk, which is the loss of lean skeletal muscle, which can induce sarcopenia or sarcopenic obesity. Given the vital role of skeletal muscle in overall health, it is crucial to accurately assess this condition using standard clinical measures. Exercise stands as the most potent countermeasure, acting as medicine to preserve muscle and improve metabolic health. Its benefits are driven by a complex interplay of mechanisms. Different exercise types trigger the release of myokines and exerkines, while a regulated inflammatory response is essential for muscle adaptation and regeneration. This regenerative process, involving muscle stem cells, is further governed by epigenetic factors and critical molecular pathways like Akt and insulin that maintain muscle mass. To optimize these effects, adequate protein intake and targeted nutritional strategies are essential, supporting muscle protein synthesis and recovery. Supplementation, particularly with leucine-rich amino acids or vitamin D, may further enhance anabolic responses, especially in older adults. Clinical monitoring of muscle mass, strength, and nutritional biomarkers should be integrated into obesity care to detect early signs of sarcopenia and guide individualized interventions. Therefore, it is imperative that obesity therapy evolves to prevent muscle loss. This review highlights the risk of therapy-induced sarcopenia from modern obesity treatments, emphasizing the need for integrated prevention strategies, centered on exercise, and reinforced by nutrition, supplementation, and clinical monitoring to ensure healthy, sustainable weight loss.KEYWORDS: sarcopenia, skeletal muscle, inflammation, obesity, incretin

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 182 tautan kepenulisan bersama · 80 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Padjadjaran University
  • Universitas Trisakti
  • Hasanuddin University
  • National Research and Innovation Agency
  • Universiti Brunei Darussalam
  • Syarif Hidayatullah State Islamic University Jakarta
  • Kyushu University
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Andi WijayaHasanuddin University132
Ferry SandraUniversitas Trisakti5
Irma Ruslina DefiPadjadjaran University4
Melisa Intan BarlianaPadjadjaran University2
Irma Rahayu LatarissaPadjadjaran University2
Keri LestariPadjadjaran University2
Ida Paulina SorminHasanuddin University2
Erizal SugionoHasanuddin University2
Ilhamjaya PatellongiHasanuddin University2
Suryani As’ádHasanuddin University2
Aziiz Mardanarian RosdiantoPadjadjaran University2
Adziqa Ammara QiantoriPadjadjaran University2
Rina TrianaPadjadjaran University2
Anna MeilanaPadjadjaran University1
Cissy Bana KartasasmitaPadjadjaran University1
Irmansyah IrmansyahNational Research and Innovation Agency1
Solachuddin Jauhari Arief IchwanUniversiti Brunei Darussalam1
Maria CelinnaAfiliasi tidak diketahui1
Andri SutantoUniversitas Trisakti1
Widya WulandariUniversitas Trisakti1
Reynaldo LambertusUniversitas Trisakti1
Melanie Sadono DjamilUniversitas Trisakti1
Laifa Annisa HendarminSyarif Hidayatullah State Islamic University Jakarta1
Dewi RanggainiUniversitas Trisakti1
Muhammad Ihsan RizalUniversitas Trisakti1
Toshio KukitaKyushu University1
Setiawan SetiawanPadjadjaran University1
Yovita HartantriPadjadjaran University1
Haig Yousef BabikianAfiliasi tidak diketahui1
Iceu Dimas KulsumPadjadjaran University1
Ferdy FerdianDr. Hasan Sadikin General Hospital1
Efriadi IsmailUniversity of Indonesia1
Yelsen SumalimAfiliasi tidak diketahui1
Prayudi SantosoPadjadjaran University1
Arief Riadi ArifinAfiliasi tidak diketahui1
Chandra Agung PurnamaPadjadjaran University1
Keri Lestari DandanPadjadjaran University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Sarcopenia as a Risk of Modern Obesity Treatments: A Review of Molecular Mechanisms and Prevention Strategies</dc:title><dc:creator>Anna Meiliana</dc:creator><dc:creator>Nurrani Mustika Dewi</dc:creator><dc:creator>Andi Wijaya</dc:creator><dc:subject>sarcopenia</dc:subject><dc:subject>sarcopenic obesity</dc:subject><dc:subject>obesity treatment</dc:subject><dc:subject>incretin-based therapy</dc:subject><dc:subject>skeletal muscle atrophy</dc:subject><dc:subject>physical activity</dc:subject><dc:subject>myokines</dc:subject><dc:subject>exerkines</dc:subject><dc:subject>muscle inflammation</dc:subject><dc:subject>muscle stem cells</dc:subject><dc:subject>epigenetics</dc:subject><dc:subject>Akt signaling</dc:subject><dc:subject>insulin signaling</dc:subject><dc:subject>muscle protein synthesis</dc:subject><dc:subject>protein intake</dc:subject><dc:subject>leucine supplementation</dc:subject><dc:subject>vitamin D supplementation</dc:subject><dc:subject>older adults</dc:subject><dc:subject>dietary biomarkers</dc:subject><dc:description xml:lang="en">While lifestyle interventions and metabolic surgery for obesity have limitations, incretin-based therapies have emerged as highly effective treatments. However, their success is shadowed by a significant risk, which is the loss of lean skeletal muscle, which can induce sarcopenia or sarcopenic obesity. Given the vital role of skeletal muscle in overall health, it is crucial to accurately assess this condition using standard clinical measures. Exercise stands as the most potent countermeasure, acting as medicine to preserve muscle and improve metabolic health. Its benefits are driven by a complex interplay of mechanisms. Different exercise types trigger the release of myokines and exerkines, while a regulated inflammatory response is essential for muscle adaptation and regeneration. This regenerative process, involving muscle stem cells, is further governed by epigenetic factors and critical molecular pathways like Akt and insulin that maintain muscle mass. To optimize these effects, adequate protein intake and targeted nutritional strategies are essential, supporting muscle protein synthesis and recovery. Supplementation, particularly with leucine-rich amino acids or vitamin D, may further enhance anabolic responses, especially in older adults. Clinical monitoring of muscle mass, strength, and nutritional biomarkers should be integrated into obesity care to detect early signs of sarcopenia and guide individualized interventions. Therefore, it is imperative that obesity therapy evolves to prevent muscle loss. This review highlights the risk of therapy-induced sarcopenia from modern obesity treatments, emphasizing the need for integrated prevention strategies, centered on exercise, and reinforced by nutrition, supplementation, and clinical monitoring to ensure healthy, sustainable weight loss.KEYWORDS: sarcopenia, skeletal muscle, inflammation, obesity, incretin</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2025-12-27</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v17i6.3583</dc:identifier><dc:identifier>10.18585/inabj.v17i6.3583</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 17 No 6 (2025); 511-526</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/3583/807</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>